AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06459921 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FLOT+Sintilimab
Description: Patients would be allocated to the FLOT+Sintilimab group.
Study NCT05403762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ESENTA™ Skin Barrier Spray (ConvaTec, UK)
Description: The skin protectant will be applied on clean and dry skin exposed to urine and stool. After application, the solvent evaporates leaving a silicone film on the skin surface.
Study NCT05403762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hydrophobes Basisgel DAC
Description: The skin protectant will be applied on clean and dry skin. It contains 95% paraffin oil and creates a hydrophobic layer on the skin surface.
Study NCT05805397 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivation Skills Training
Description: Participants will complete a baseline assessment, receive weekly MST sessions in a group format for a duration of 12 weeks, and will then repeat the assessment battery from baseline immediately following treatment completion and 2-months after.
Study NCT05805397 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Behaviors Control Group
Description: Participants will complete a baseline assessment, receive weekly HBC sessions in a group format for a duration of 12 weeks, and will repeat the assessment battery from baseline immediately following treatment completion and 2-months after.
Study NCT06012760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron sucrose, Human Erythropoietin Injection, Vitamin C
Description: The participants were administered a combined iron supplementation regimen consisting of iron sucrose,Human Erythropoietin Injection, and vitamin C, three times throughout the preoperative week.
Study NCT06012760 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Medical Care
Description: Standard Medical Care (SMC) for the treatment of IDA. SMC as determined by the Investigator for the treatment of iron deficiency anemia (IDA).
Study NCT04882683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: 0.75 mg per kilogram per day for three months
Study NCT04882683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azathioprine
Description: 1 mg per kilogram per day for three months
Study NCT04882683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab
Description: 40mg every two weeks for three months
Study NCT04882683 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: umbilical cord blood mononuclear cells
Description: Peripheral intravenous infusion method, infusion of umbilical cord blood mononuclear cell suspension 50ml (cell number 2×10\^8).
Study NCT05751395 — intervention group
Intervention type: DEVICE
Intervention: Central Venous Access
Description: Critically ill patients in severe MODS need a CVC and in some cases also a second line for e-g- blood purification techniques.~All CVCs are positioned via the ECG method with the CVC tip placed at P-max. Within 24 h a chest radiograph is obtained for assessment of the CVCs, especially their tips.
Study NCT06383377 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tooth extraction and bone graft procedure
Description: The subject will receive a flash dose of 2 gr of amoxicillin or 600 mg of Clindamycin 1 hour before the surgery.~Tooth will be extracted using gentle techniques to guarantee an atraumatic extraction. If the socket presents insufficient bleeding, the clinician must use an appropriate procedure to induce bleeding. The extraction site must be carefully cleaned. Extraction socket will then be filled with WHA or Bio-Oss previously hydrated with saline solution (0.9%). Extraction socket packed with the graft will be covered with a collagen sponge (Geistlich Mucograft® Seal) and sutured (cross suture, Vicryl rapide 4.0).~If required, a limited connective tissue graft can be placed in the vestibular region.~A CBCT scan will be performed after the bone graft procedure, i.e., after the extraction socket and the biomaterial placement, to measure the initial bone width.~The safety of the investigational device will be evaluated.
Study NCT06383377 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tooth extraction and bone graft procedure
Description: The subject will receive a flash dose of 2 gr of amoxicillin or 600 mg of Clindamycin 1 hour before the surgery.~Tooth will be extracted using gentle techniques to guarantee an atraumatic extraction. If the socket presents insufficient bleeding, the clinician must use an appropriate procedure to induce bleeding. The extraction site must be carefully cleaned. Extraction socket will then be filled with WHA or Bio-Oss previously hydrated with saline solution (0.9%). Extraction socket packed with the graft will be covered with a collagen sponge (Geistlich Mucograft® Seal) and sutured (cross suture, Vicryl rapide 4.0).~If required, a limited connective tissue graft can be placed in the vestibular region.~A CBCT scan will be performed after the bone graft procedure, i.e., after the extraction socket and the biomaterial placement, to measure the initial bone width.~The safety of the investigational device will be evaluated.
Study NCT04184375 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive stimulation
Description: Patients participate in one session per week according to the following schedule:~* 2 sensory stimulation sessions: identify sensations, emotions, how to manage them.~* 2 sessions on association, verbal fluency, and imagination: language as a tool for expression in the face of illness.~* 2 voluntary attention sessions: improve daily attention.~* 2 sessions of intellectual structuring: stimulating and maintaining memory, carrying out external activities.~* 2 sessions of structuring through language: impact on social life.~* 2 sessions stimulating the temporal and spatial landmarks: agenda, daily trips.
Study NCT05610930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Front-of-pack label NutriScore 2.0
Description: Participants in the experimental arm can see, in case the product is ultra-processed, a black banner surrounding the Nutri-Score, with the word ultra-transformé, meaning ultra-processed, and no black banner otherwise. Participants in the control arm had no label at all. The intervention (the Nutri-Score 2.0) was added on the packaging on the products included in the 3 sets of images that participants recieved via the questionnaire.
Study NCT06471842 — intervention group
Intervention type: OTHER
Intervention: MCH (Montreal Children's Hospital) feeding scale questionnaire and parental questionnaire
Description: The patient's parents will answer the questionnaire and the investigator will complete the parental questionnaire while asking the questions.
Study NCT06312085 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endofill
Description: Endofill is intended for the permanent obturation of root canals following root canal preparation and disinfection.
Study NCT05747365 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood and urine diagnostic evaluation
Description: Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations
Study NCT06093828 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: TriFlo Tricuspid Flow Optimizer
Description: An introducer sheath is inserted into the femoral vein over a stiff guidewire; the sheath extends into the common iliac vein and inferior vena cava and in the right atrium. The TFO device is oriented coaxiality to the tricuspid. Once released, the delivery catheter and the steerable catheter are removed the access site closure performed by a cardiovascular or vascular surgeon or with pre-implanted percutaneous sutures per site preference.
Study NCT06458725 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Magnetic Resonance Imaging (MRI)
Description: - Three MRI :~* two on an MR-Linac 1.5 Tesla (10 to 17 days apart)~* one on a standard 1.5 Tesla MRI
Study NCT05940883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Y-2 Sublingual Tablet
Description: Subjects will receive one Y-2 sublingual tablet sublingually once daily for Day1 and Day 19 and twice daily for Day 6 to Day 18.
Study NCT05940883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Y-2 Sublingual Tablet
Description: Subjects will receive two Y-2 sublingual tablets sublingually once daily for Day1 and Day 19 and twice daily for Day 6 to Day 18.
Study NCT05940883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Y-2 Sublingual Tablet
Description: Subjects will receive Y-2 sublingual tablet with 3 different conditions once daily for Day1 Day 6 and Day 11. Day 1 with condition A, Day 6 with condition B and Day 11 with condition C.
Study NCT05940883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Y-2 Sublingual Tablet
Description: Subjects will receive Y-2 sublingual tablet with 3 different conditions once daily for Day1 Day 6 and Day 11. Day 1 with condition B, Day 6 with condition C and Day 11 with condition A.
Study NCT05940883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Y-2 Sublingual Tablet
Description: Subjects will receive Y-2 sublingual tablet with 3 different conditions once daily for Day1 Day 6 and Day 11. Day 1 with condition C, Day 6 with condition A and Day 11 with condition B.
Study NCT05940883 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, sublingually, single and multiple ascending dosing in group 1 and 2 subjects.
Study NCT05521490 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care Control
Description: 30 minutes of physical activity on each school day.
Study NCT05521490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Enhanced Curriculum
Description: Additional 2.5 hours of physical activity per week in addition to the stipulated 30 minutes of daily physical activity.
Study NCT05308862 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care process for assessements of risks
Description: Intervention aiming to reduce the risk of pressure ulcers, malnutrition, poor oral health and falls among older persons in nursing homes, workshops will be conducted in collaboration with nurse aides, registered nurses and managers. Cluster randomization is going to take place via a computerized program prior to the workshops meaning that only those nurse aides, registered nurses and managers working in nursing homes allocated to the intervention group are going to develop an intervention together with the research group and then test it .
Study NCT06042647 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.01% Halobetasol
Description: Drug to be applied at bedtime to designated target psoriasis plaque at bedtime.
Study NCT06042647 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.045% Tazarotene
Description: Drug to be applied in combination with 0.01% Halobetasol to the designated psoriasis plaque at bedtime.
Study NCT06042647 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.05% Clobetasol Propionate
Description: Drug to be applied to designated psoriatic plaque at bedtime.
Study NCT05401149 — intervention group
Intervention type: DRUG
Intervention: rt-PA
Description: Recombinant Tissue Plasminogen Activator
Study NCT05282316 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: EVOO polyphenols enriched
Description: Addition of 40 ml daily of healthy polyphenols enriched EVOO to mediterranean diet for 6 months
Study NCT05282316 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: EVOO standard
Description: Addition of 40 ml daily of standard EVOO to mediterranean diet for 6 months
Study NCT05039047 — intervention group
Intervention type: OTHER
Intervention: Standard stroke acute care and rehabilitation
Description: According to Swiss national guidelines and local protocols
Study NCT04148443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preoxygenation
Description: participants will receive 3 minutes of preoxygenation before intubation
Study NCT04148443 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preoxygenation (longer)
Description: participants will receive 5 minutes of preoxygenation before intubation
Study NCT05637021 — intervention group
Intervention type: OTHER
Intervention: Carbon dioxide insufflated during colonoscopy
Description: Carbon dioxide is insufflated to dilate the bowel lumen during colonoscopy.Record the amount of gas insufflated during colonoscopy.
Study NCT05930327 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unconditional Cash Transfer (High-Value)
Description: Monthly, Unconditional Cash Transfer ($325) for 4-months
Study NCT05930327 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Unconditional Cash Transfer (Low-Value)
Description: Monthly, Unconditional Cash Transfer ($25) for 4-months
Study NCT05767944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: local anaesthesia infiltration
Description: Infiltration of 150 mg of lidocaine solution per ray at site of surgical incision for flexor tendon repair in the palm, the 2 proximal \& distal phalanges
Study NCT05767944 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: brachial plexus block
Description: ultrasound-guided infiltration of local aesthetics around brachial plexus trunks \& divisions
Study NCT05106231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PICC Program
Description: Participants will attend the PICC program which consists of 4 sessions that involve Visualization in Participatory Programmes (VIPP) and quizzes to evaluate retention in diabetes knowledge.
Study NCT05106231 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control arm received four sessions one-on-one education program by a pharmacist. It is a Malaysian national education pharmacy-led program to instil knowledge and inculcate medication adherence.
Study NCT04287452 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Control
Study NCT04287452 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dog Therapy
Description: Exposure to certified therapy dogs and their handler.
Study NCT05036915 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pacifier randomly
Description: Common Action Steps:~1. Legal representatives of newborns are informed about the study purpose, participants read and sign the informed consent form so their consent is obtained.~2. Inclusion and exclusion criteria are evaluated.~3. Study group is determined in line with the randomization order of the newborn to be included in the study.~4. First part of the patient information and follow-up form is completed.~5. Feeding content, amount and method are determined by the physician.~Action Steps of the Control Group:~\* Pacifier is randomly given to the infant for 30 min independent from feeding during the day.~1. Common procedure steps are applied.~2. Procedure steps are applied in accordance with the Neonatal Nursing Protocols according to the newborn's feeding method.~3. Second part of the patient information and follow-up form is completed daily.
Study NCT05036915 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pacifier other
Description: Procedure Steps of the Experimental Group:~* Pacifier is randomly given to the infant for 30 min independent from feeding during the day. In addition, pacifier is given to the infant for 5 min before each feeding.~  1. Common procedure steps are applied.~ 2. Pacifier is given for 5 min before each feeding.~ 3. Procedure steps are applied in accordance with the Neonatal Nursing Protocols according to the newborn's feeding method.~ 4. Second part of the patient information and follow-up form is completed daily.
Study NCT05664750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TNM002
Description: Dosage Form: Injection, solution~Route of administration: IM gluteal injection
Study NCT05570682 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TCI
Description: General anesthesia will be induced with a TCI pump
Study NCT05570682 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual induction
Description: General anestehsia will be induced and maintained using a pro kilo regimen.
Study NCT04740515 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacists involved PPMTM
Description: This was an open labelled randomised study. Preterm Infants With iron supplementation were recruited and arbitrarily divided into the intervention group (usual care plus PPMTM) and the non-intervention group (usual care only). Those enrolled in the research were scheduled for follow-up for eight consecutive visits. Improvements in lab results and direct costs were compared longitudinally (pre and post analysis) between the groups.
Study NCT00518024 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Bilateral Theta Burst Stimulation
Study NCT00518024 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Bilateral Theta Burst Stimulation
Study NCT05004324 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL
Description: the following study drug is injected respectively into both upper arms, both thighs, and abdomen (total of 5 regions)
Study NCT05004324 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL
Description: the following study drug is injected respectively into both upper arms, both thighs, and abdomen (total of 5 regions)
Study NCT05004324 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: the following study drug is injected respectively into both upper arms, both thighs, and abdomen (total of 5 regions)
Study NCT05004324 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: the following study drug is injected respectively into both upper arms, both thighs, and abdomen (total of 5 regions)
Study NCT05585424 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AOT intervention
Description: The treatment will last 4 weeks, with an intensity of 3 sessions per week. During the sessions the MCI patient will observe his MCI partner and perform a programme of upper limb motor activities. At the same time the mild patient imitates the movement performed by the physiotherapist, all based on the AOT.~The activities will be based on items of the FUGL-MEYER scale. The sessions will last between 15 and 20 minutes and will be held three days a week. The intervention will last 5 weeks, with an initial assessment, 11 intervention sessions and a final assessment.
Study NCT05234164 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EXIST 6F NiTi Stent System FLEX
Description: Subjects requiring treatment of the P1 segment of the proximal popliteal artery will be treated with the Exist 6F NiTi Stent FLEX type. Subjects requiring treatment of the SFA will undergo an additional calcification review based on the Fanelli classification. Subjects graded with Fanelli 1 or 2 will be treated with the Exist 6F NiTi Stent FLEX type.
Study NCT05234164 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EXIST 6F NiTi Stent System PULL
Description: Subjects requiring treatment of the SFA will undergo a calcification review based on the Fanelli classification. Subjects graded with Fanelli grade 3 and 4 will be treated with the Exist 6F NiTi Stent PULL type.
Study NCT04867564 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Traditional echocardiography and speckle tracking echocardiography (STE) before and 1, 6, and 12 months after RT
Study NCT05548595 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Investigational
Description: 2 tablets are taken with water around the same time every day, ideally after a meal
Study NCT05548595 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 tablets are taken with water around the same time every day, ideally after a meal
Study NCT05247151 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: Oxytocin nasal spray in a positive social setting.
Study NCT05247151 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo nasal spray in a positive social setting.
Study NCT06288984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active rTMS
Description: The magnetic stimulation coil was tangent to the scalp and kept parallel for 10 minutes a day, 5 days a week for 4 weeks
Study NCT06288984 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham rTMS
Description: The magnetic stimulation coil was tangent to the scalp and kept perpendicular for 10 minutes a day, 5 days a week for 4 weeks
Study NCT04728243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WHO QualityRights e-training
Description: The WHO QualityRights online training aims to increase knowledge about the rights of people with psychosocial disabilities and change negative attitudes towards these persons and their role as rights holders. Furthermore, the training provides mental health professionals with the skills necessary to support people with psychosocial disabilities to advocate for their rights. The WHO QualityRights online training includes five core modules: 1) Human rights; 2) Mental health, disability, and human rights; 3) The right to health and recovery; 4) Legal capacity and the right to decide; 5) Free from coercion, violence, and abuse. Each module is composed of presentations, videos, interactive exercises, and forum discussions involving all participants. In the online training forum discussions, particular attention will be given to issues relevant to the Ghanaian context.